SCHEMBL6180284

SCHEMBL6180284

O=S(=O)(c1ccc(Cl)cc1)N1CCC[C@H]1c1cccs1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 4/20 0.79
PSEN1 P49768 3/20 0.60
PSEN2 P49810 3/20 0.60
APH1B Q8WW43 3/20 0.60
NCSTN Q92542 3/20 0.60
APH1A Q96BI3 3/20 0.60
PSENEN Q9NZ42 3/20 0.60
HSD17B10 Q99714 2/20 0.58
ALDH1A1 P00352 4/20 0.51
TSHR P16473 1/20 0.51
SMN1; SMN2 Q16637 1/20 0.51
NPSR1 Q6W5P4 1/20 0.49
KDM4E B2RXH2 1/20 0.48
HTT P42858 1/20 0.48
MAPT P10636 1/20 0.48
CA1 P00915 1/20 0.48
CA2 P00918 1/20 0.48
TRPA1 O75762 1/20 0.48
GAA P10253 1/20 0.47
USP2 O75604 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6180279 1.00 LMNA (0.79) LMNAPSEN1PSEN2APH1BNCSTN
SCHEMBL6177254 0.87 LMNA (0.79) LMNAALDH1A1TSHRSMN1; SMN2NPSR1
SCHEMBL6177256 0.87 LMNA (0.79) LMNAALDH1A1TSHRSMN1; SMN2NPSR1
SCHEMBL6178702 0.87 LMNA (0.79) LMNAALDH1A1TSHRSMN1; SMN2HTT
SCHEMBL6178698 0.87 LMNA (0.79) LMNAALDH1A1TSHRSMN1; SMN2HTT
SCHEMBL6179987 0.79 PSEN1 (0.79) LMNAPSEN1PSEN2APH1BNCSTN
SCHEMBL6179985 0.79 PSEN1 (0.79) LMNAPSEN1PSEN2APH1BNCSTN
SCHEMBL6180512 0.79 LMNA (0.65) LMNAALDH1A1KDM4EMAPTTRPA1
SCHEMBL6175850 0.79 PSEN1 (0.92) LMNAPSEN1PSEN2APH1BNCSTN
SCHEMBL6175853 0.79 PSEN1 (0.92) LMNAPSEN1PSEN2APH1BNCSTN

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1165510-B1 1-ARENESULFONYL-2-ARYL-PYRROLIDINE AND PIPERIDINE DERIVATIVES FOR THE TREATMENT OF CNS DISORDERS HOFFMANN LA ROCHE (CH) 2005-09-28 EP claimed
US-6284785-B1 HAVING ACTIVITY AS LIGANDS OF METABOTROPIC GLUTAMATE RECEPTORS HOFFMANN- LA ROCHE INC. 2001-09-04 US claimed
EP-1165510-B1 1-ARENESULFONYL-2-ARYL-PYRROLIDINE AND PIPERIDINE DERIVATIVES FOR THE TREATMENT OF CNS DISORDERS HOFFMANN LA ROCHE (CH) 2005-09-28 EP disclosed
US-6284785-B1 HAVING ACTIVITY AS LIGANDS OF METABOTROPIC GLUTAMATE RECEPTORS HOFFMANN- LA ROCHE INC. 2001-09-04 US disclosed